Bedah Kardiovaskuler
Penanganan Anemia Praoperatif dan Optimasi Jumlah Sel Darah Merah
Ferric carboxymaltose in patients with heart failure and iron deficiency. (terbuka di window baru)
Sumber: N Engl J Med 2009;361(25):2436-48.
Index: PubMed 19920054
DOI: 10.1056/NEJMoa0908355
https://www.ncbi.nlm.nih.gov/pubmed/19920054 (terbuka di window baru)
Successful repair of a giant abdominal aortoiliac aneurysm in a Jehovah's Witness. (terbuka di window baru)
Sumber: Vasc Endovascular Surg 2007;41(5):460-2.
Index: PubMed 17942864
DOI: 10.1177/1538574407303172
https://www.ncbi.nlm.nih.gov/pubmed/17942864 (terbuka di window baru)
Blood loss and transfusion rates associated with transcatheter aortic valve replacement: recommendations for patients who refuse blood transfusion. (terbuka di window baru)
Sumber: Catheter Cardiovasc Interv 2014;83(6):E221-6.
Index: PubMed 24402965
DOI: 10.1002/ccd.25389
https://www.ncbi.nlm.nih.gov/pubmed/24402965 (terbuka di window baru)
Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. (terbuka di window baru)
Sumber: Anesth Analg 2019;128(5):981-92.
Index: PubMed 30649068
DOI: 10.1213/ANE.0000000000004005
https://www.ncbi.nlm.nih.gov/pubmed/30649068 (terbuka di window baru)
Epoetin dosing for blood conservation in Jehovah's Witness patients undergoing cardiac surgery—a systematic review. (terbuka di window baru)
Sumber: Can J Cardiol 2014;30(Suppl):S234.
DOI: 10.1016/j.cjca.2014.07.398
http://www.onlinecjc.ca/article/S0828-282X(14)00876-9/abstract (terbuka di window baru)
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. (terbuka di window baru)
Sumber: Am J Cardiol 2012;110(7):1021-6.
Index: PubMed 22771376
DOI: 10.1016/j.amjcard.2012.05.036
https://www.ncbi.nlm.nih.gov/pubmed/22771376 (terbuka di window baru)
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial. (terbuka di window baru)
Sumber: Eur J Heart Fail 2013;15(11):1267-76.
Index: PubMed 23787722
DOI: 10.1093/eurjhf/hft099
https://www.ncbi.nlm.nih.gov/pubmed/23787722 (terbuka di window baru)
Current status of pharmacologic therapies in patient blood management. (terbuka di window baru)
Sumber: Anesth Analg 2013;116(1):15-34.
Index: PubMed 23223098
DOI: 10.1213/ANE.0b013e318273f4ae
https://www.ncbi.nlm.nih.gov/pubmed/23223098 (terbuka di window baru)
Intraoperative anemia and single red blood cell transfusion during cardiac surgery: an assessment of postoperative outcome including patients refusing blood transfusion. (terbuka di window baru)
Sumber: J Cardiothorac Vasc Anesth 2016;30(2):363-72.
Index: PubMed 26809765
DOI: 10.1053/j.jvca.2015.10.021
https://www.ncbi.nlm.nih.gov/pubmed/26809765 (terbuka di window baru)
The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. (terbuka di window baru)
Sumber: Transfusion 2008;48(4):666-72.
Index: PubMed 18194382
DOI: 10.1111/j.1537-2995.2007.01590.x
https://www.ncbi.nlm.nih.gov/pubmed/18194382 (terbuka di window baru)
Randomised open-label trial comparing intravenous iron and an erythropoiesis-stimulating agent versus oral iron to treat preoperative anaemia in cardiac surgery (INITIATE trial). (terbuka di window baru)
Sumber: Br J Anaesth. 2022;128(5):796-805.
Index: PubMed 35256150
DOI: 10.1016/j.bja.2022.01.034
https://pubmed.ncbi.nlm.nih.gov/35256150/ (terbuka di window baru)
Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. (terbuka di window baru)
Sumber: Transfus Med Rev 2013;27(4):221-34.
Index: PubMed 24135037
DOI: 10.1016/j.tmrv.2013.09.001
https://www.ncbi.nlm.nih.gov/pubmed/24135037 (terbuka di window baru)
The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? (terbuka di window baru)
Sumber: J Thorac Cardiovasc Surg 2013;146(6):1480-7.e6.
Index: PubMed 23998782
DOI: 10.1016/j.jtcvs.2013.06.033
https://www.ncbi.nlm.nih.gov/pubmed/23998782 (terbuka di window baru)
Jehovah's Witnesses and cardiac surgery: a single institution's experience. (terbuka di window baru)
Sumber: Transfusion 2014;54(10 Pt 2):2745-52.
Index: PubMed 24809815
DOI: 10.1111/trf.12696
https://www.ncbi.nlm.nih.gov/pubmed/24809815 (terbuka di window baru)
Determining optimal treatment to correct preoperative anemia and reduce perioperative allogeneic blood transfusions in cardiac surgery: a retrospective cohort study. (terbuka di window baru)
Sumber: J Cardiothorac Vasc Anesth 2021;35(9):2631-9.
Index: PubMed 33483268
DOI: 10.1053/j.jvca.2020.12.044
https://pubmed.ncbi.nlm.nih.gov/33483268/ (terbuka di window baru)
Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (terbuka di window baru)
Sumber: Surg Infect (Larchmt) 2009;10(1):9-19.
Index: PubMed 19245362
DOI: 10.1089/sur.2008.043
https://www.ncbi.nlm.nih.gov/pubmed/19245362 (terbuka di window baru)
Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial. (terbuka di window baru)
Sumber: Anaesthesia 2020;75(8):1039-49.
Index: PubMed 32342498
DOI: 10.1111/anae.15062
https://www.ncbi.nlm.nih.gov/pubmed/32342498 (terbuka di window baru)
Preoperative erythropoietin and blood conservation management for thoracoabdominal aneurysm repair in a Jehovah's Witness. (terbuka di window baru)
Sumber: J Vasc Surg 2003;37(2):453-5.
Index: PubMed 12563221
DOI: 10.1067/mva.2003.73
https://www.ncbi.nlm.nih.gov/pubmed/12563221 (terbuka di window baru)
Intravenous iron in heart failure: beyond targeting anemia. (terbuka di window baru)
Sumber: Curr Heart Fail Rep 2011;8(1):14-21.
Index: PubMed 21057903
DOI: 10.1007/s11897-010-0034-4
https://www.ncbi.nlm.nih.gov/pubmed/21057903 (terbuka di window baru)
Cardiovascular surgery in Jehovah's Witness patients: the role of preoperative optimization. (terbuka di window baru)
Sumber: J Thorac Cardiovasc Surg 2015;150(4):976-83.e1-3.
Index: PubMed 26211405
DOI: 10.1016/j.jtcvs.2015.06.059
https://www.ncbi.nlm.nih.gov/pubmed/26211405 (terbuka di window baru)
Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. (terbuka di window baru)
Sumber: J Nephrol 2008;21(2):236-42.
Index: PubMed 18446719
https://www.ncbi.nlm.nih.gov/pubmed/18446719 (terbuka di window baru)
Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. (terbuka di window baru)
Sumber: J Thorac Cardiovasc Surg 2010;139(3):621-7.
Index: PubMed 20042202
DOI: 10.1016/j.jtcvs.2009.10.012
https://www.ncbi.nlm.nih.gov/pubmed/20042202 (terbuka di window baru)
A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. (terbuka di window baru)
Sumber: Transfusion 2015;55(7):1644-54.
Index: PubMed 25702777
DOI: 10.1111/trf.13027
https://www.ncbi.nlm.nih.gov/pubmed/25702777 (terbuka di window baru)
Blood conservation strategies can be applied safely to high-risk complex aortic surgery. (terbuka di window baru)
Sumber: J Cardiothorac Vasc Anesth 2015;29(3):703-9.
Index: PubMed 25847415
DOI: 10.1053/j.jvca.2014.10.022
https://www.ncbi.nlm.nih.gov/pubmed/25847415 (terbuka di window baru)
Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. (terbuka di window baru)
Sumber: Anesthesiology 2011;115(5):929-37.
Index: PubMed 22027622
DOI: 10.1097/ALN.0b013e318232004b
https://www.ncbi.nlm.nih.gov/pubmed/22027622 (terbuka di window baru)